Xuejiao Liu

xuzhou medical university

H指数:22

被引数:1,339

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

RETRACTION: GRP78 determines glioblastoma sensitivity to UBA1 inhibition-induced UPR signaling and cell death (vol 15, 188, 2024) (Retraction of Vol 15, art no 799, 2024)

CELL DEATH & DISEASE

IF9.6

2024-03-050

OAAI

Microglia TREM1-mediated neuroinflammation contributes to central sensitization via the NF-κB pathway in a chronic migraine model

在慢性偏头痛模型中，小胶质细胞TREM1-mediated神经炎症通过nf-κb途径促进中枢敏化

JOURNAL OF HEADACHE AND PAIN

IF7.9

2024-01-0517

OAAI

Preclinical evaluation of Mito-LND, a targeting mitochondrial metabolism inhibitor, for glioblastoma treatment

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2023-08-077

OAAI

MELK Inhibition Effectively Suppresses Growth of Glioblastoma and Cancer Stem-Like Cells by Blocking AKT and FOXM1 Pathways (vol 10, 608062, 2021)

FRONTIERS IN ONCOLOGY

IF3.3

2022-04-220

OAAI

GRP78 blockade overcomes intrinsic resistance to UBA1 inhibitor TAK-243 in glioblastoma

CELL DEATH DISCOVERY

IF7

2022-03-2811

OAAI

RETRACTED: GRP78 determines glioblastoma sensitivity to UBA1 inhibition-induced UPR signaling and cell death (Retracted Article)

CELL DEATH & DISEASE

IF9.6

2021-07-2318

OAAI

G-Quadruplex-Induced Liquid-Liquid Phase Separation in Biomimetic Protocells

仿生原始细胞中G-四链体诱导的液-液相分离

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

IF15.6

2021-07-1634

PREAI

MELK Inhibition Effectively Suppresses Growth of Glioblastoma and Cancer Stem-Like Cells by Blocking AKT and FOXM1 Pathways

FRONTIERS IN ONCOLOGY

IF3.3

2021-01-1421

OAAI

BYSL contributes to tumor growth by cooperating with the mTORC2 complex in gliomas

CANCER BIOLOGY & MEDICINE

IF8.4

2021-01-0121

OAAI

MALT1 Inhibition as a Therapeutic Strategy in T-Cell Acute Lymphoblastic Leukemia by Blocking Notch1-Induced NF-κB Activation

通过阻断Notch1-Induced nf-κb活化抑制MALT1作为T细胞急性淋巴细胞白血病的治疗策略

FRONTIERS IN ONCOLOGY

IF3.3

2020-09-2311

OAAI

SWAP-70 promotes glioblastoma cellular migration and invasion by regulating the expression of CD44s

SWAP-70通过调控CD44s的表达促进胶质母细胞瘤细胞迁移和侵袭

CANCER CELL INTERNATIONAL

IF6

2019-11-217

OAAI

MiR-340 Is a Biomarker for Selecting Treatment Between Chemotherapy and Allogeneic Transplantation in Acute Myeloid Leukemia

FRONTIERS IN ONCOLOGY

IF3.3

2019-10-113

OAAI

Selective inhibition of Aurora A and B kinases effectively induces cell cycle arrest in t(8;21) acute myeloid leukemia

选择性抑制Aurora A和B激酶可有效诱导t(8;21) 急性髓系白血病细胞周期停滞

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2019-09-0114

OAAI

The third-generation EGFR inhibitor AZD9291 overcomes primary resistance by continuously blocking ERK signaling in glioblastoma

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2019-05-2384

OAAI

High expression of miR-25 predicts favorable chemotherapy outcome in patients with acute myeloid leukemia

CANCER CELL INTERNATIONAL

IF6

2019-05-076

OAAI

High expression of miR-363 predicts poor prognosis and guides treatment selection in acute myeloid leukemia

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2019-04-0112

OAAI

MiR-425 expression profiling in acute myeloid leukemia might guide the treatment choice between allogeneic transplantation and chemotherapy

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2018-10-0116

OAAI

The atypical protein kinase RIOK3 contributes to glioma cell proliferation/survival, migration/invasion and the AKT/mTOR signaling pathway

CANCER LETTERS

IF10.1

2018-02-0148

PREAI

Hypoxia-responsive lipid-poly-(hypoxic radiosensitized polyprodrug) nanoparticles for glioma chemo- and radiotherapy

THERANOSTICS

IF13.3

2018-01-01100

OAAI

Effects of ERK1/2 S-nitrosylation on ERK1/2 phosphorylation and cell survival in glioma cells

ERK1/2 s-亚硝基化对神经胶质瘤细胞ERK1/2磷酸化和细胞存活的影响

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

IF5.8

2017-12-2027

OAAI

Xuejiao Liu

个人简介

教育背景

工作经历

荣誉奖项

研究方向